Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors. - Lappin KM; Barros EM; Jhujh SS; Irwin GW; McMillan H; Liberante FG; Latimer C; La Bonte MJ; Mills KI; Harkin DP; Stewart GS; Savage KI (Cancer research, 2022)